Evidence map›Paper›PMID 30394185›Full record

ArticlePrion2018

Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Fumiko Furukawa, Nobuo Sanjo, Atsushi Kobayashi, Tsuyoshi Hamaguchi, Masahito Yamada, Tetsuyuki Kitamoto, Hidehiro Mizusawa, Takanori Yokota

Open access · goldAbstract readCase Reports
In one paragraph

Article in Prion, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Fumiko Furukawaa Department of Neurology and Neurological Science , Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences , Yushima Bunkyo-ku , Tokyo , Japan.
Nobuo Sanjoa Department of Neurology and Neurological Science , Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences , Yushima Bunkyo-ku , Tokyo , Japan.ORCID 0000-0002-1226-2425
Atsushi Kobayashib Laboratory of Comparative Pathology , Hokkaido University, Graduate School of Veterinary Medicine , Kita-ku, Sapporo , Hokkaido , Japan.
Tsuyoshi Hamaguchic Department of Neurology and Neurobiology of Aging , Kanazawa University Graduate School of Medical Science , Kanazawa , Japan.
Masahito Yamadac Department of Neurology and Neurobiology of Aging , Kanazawa University Graduate School of Medical Science , Kanazawa , Japan.
Tetsuyuki Kitamotod Department of Neurological Science , Tohoku University Graduate School of Medicine , Sendai , Japan.
Hidehiro Mizusawae National Center of Neurology and Psychiatry , Tokyo , Japan.
Takanori Yokotaa Department of Neurology and Neurological Science , Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences , Yushima Bunkyo-ku , Tokyo , Japan.
Tokyo Medical and Dental University · JPKanazawa University · JPHokkaido University · JPNational Center of Neurology and Psychiatry · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although colocalization of amyloid β (Aβ) with prion protein (PrP) in the kuru plaque has previously been observed in the brain of prion diseases patients, the participating Aβ species has not been identified. Here, we present an immunohistochemical assessment of the brain and spinal cord of a 69-year-old Japanese female patient with Gerstmann-Sträussler-Scheinker disease with a P105L mutation on the PRNP gene (GSS-P105L). Immunohistochemical assessment of serial brain sections was performed using anti-PrP and -Aβ antibodies in the hippocampus, frontal and occipital lobes. She died 69 years after a 21-year clinical course. Immunohistochemistorical examination revealed that ~50% of the kuru plaques in the cerebrum were colocalized with Aβ, and Aβ42 was predominantly observed to be colocalized with PrP-plaques. The Aβ deposition patterns were unique, and distinct from diffuse plaques observed in the normal aging brain or Alzheimer's disease brain. The spinal cord exhibited degeneration in the lateral corticospinal tract, posterior horn, and fasciculus gracilis. We have demonstrated for the first time that Aβ42, rather than Aβ40, is the main Aβ component associated with PrP-plaques, and also the degeneration of the fasciculus gracilis in the spinal cord in GSS-P105L, which could be associated with specific clinical features of GSS-P105L.

Indexed as

AgedAmino Acid SubstitutionAmyloid beta-PeptidesBrainFatal OutcomeFemaleGerstmann-Straussler-Scheinker DiseaseHumansImmunohistochemistryMutation, MissensePeptide FragmentsPlaque, AmyloidPrion ProteinsSpinal CordAmyloid beta-Peptidesamyloid beta-protein (1-42)Peptide FragmentsPrion ProteinsPRNP protein, humanAmyloid-β42colocalizationfasciculus graciliGerstmann-Sträussler-Scheinker diseaseP105Lprion protein

Identifiers

PMID30394185
PMCPMC6277180
OpenAlexW2899890376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.